These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 32763630)

  • 1. Physiologically based kinetic (PBK) modelling and human biomonitoring data for mixture risk assessment.
    Pletz J; Blakeman S; Paini A; Parissis N; Worth A; Andersson AM; Frederiksen H; Sakhi AK; Thomsen C; Bopp SK
    Environ Int; 2020 Oct; 143():105978. PubMed ID: 32763630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human biomonitoring initiative (HBM4EU): Human biomonitoring guidance values (HBM-GVs) derived for bisphenol A.
    Ougier E; Zeman F; Antignac JP; Rousselle C; Lange R; Kolossa-Gehring M; Apel P
    Environ Int; 2021 Sep; 154():106563. PubMed ID: 33894553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human biomonitoring and toxicokinetics as key building blocks for next generation risk assessment.
    Reale E; Zare Jeddi M; Paini A; Connolly A; Duca R; Cubadda F; Benfenati E; Bessems J; S Galea K; Dirven H; Santonen T; M Koch H; Jones K; Sams C; Viegas S; Kyriaki M; Campisi L; David A; Antignac JP; B Hopf N
    Environ Int; 2024 Feb; 184():108474. PubMed ID: 38350256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxicity Weighting for Human Biomonitoring Mixture Risk Assessment: A Proof of Concept.
    Loh MM; Schmidt P; Christopher de Vries Y; Vogel N; Kolossa-Gehring M; Vlaanderen J; Lebret E; Luijten M
    Toxics; 2023 Apr; 11(5):. PubMed ID: 37235224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Towards a systematic use of effect biomarkers in population and occupational biomonitoring.
    Zare Jeddi M; Hopf NB; Viegas S; Price AB; Paini A; van Thriel C; Benfenati E; Ndaw S; Bessems J; Behnisch PA; Leng G; Duca RC; Verhagen H; Cubadda F; Brennan L; Ali I; David A; Mustieles V; Fernandez MF; Louro H; Pasanen-Kase R
    Environ Int; 2021 Jan; 146():106257. PubMed ID: 33395925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of human biomonitoring (HBM) of chemical exposure in the characterisation of health risks under REACH.
    Boogaard PJ; Aylward LL; Hays SM
    Int J Hyg Environ Health; 2012 Feb; 215(2):238-41. PubMed ID: 22177527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human biomonitoring assessment values: approaches and data requirements.
    Angerer J; Aylward LL; Hays SM; Heinzow B; Wilhelm M
    Int J Hyg Environ Health; 2011 Sep; 214(5):348-60. PubMed ID: 21764371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interpreting human biomonitoring data in a public health risk context using Biomonitoring Equivalents.
    Hays SM; Aylward LL
    Int J Hyg Environ Health; 2012 Feb; 215(2):145-8. PubMed ID: 22192580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human biomonitoring: state of the art.
    Angerer J; Ewers U; Wilhelm M
    Int J Hyg Environ Health; 2007 May; 210(3-4):201-28. PubMed ID: 17376741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human biomonitoring in health risk assessment in Europe: Current practices and recommendations for the future.
    Louro H; Heinälä M; Bessems J; Buekers J; Vermeire T; Woutersen M; van Engelen J; Borges T; Rousselle C; Ougier E; Alvito P; Martins C; Assunção R; Silva MJ; Pronk A; Schaddelee-Scholten B; Del Carmen Gonzalez M; de Alba M; Castaño A; Viegas S; Humar-Juric T; Kononenko L; Lampen A; Vinggaard AM; Schoeters G; Kolossa-Gehring M; Santonen T
    Int J Hyg Environ Health; 2019 Jun; 222(5):727-737. PubMed ID: 31176761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The European Human Biomonitoring Initiative (HBM4EU): Human biomonitoring guidance values for selected phthalates and a substitute plasticizer.
    Lange R; Apel P; Rousselle C; Charles S; Sissoko F; Kolossa-Gehring M; Ougier E
    Int J Hyg Environ Health; 2021 May; 234():113722. PubMed ID: 33711757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interpreting biomonitoring data: Introducing the international human biomonitoring (i-HBM) working group's health-based guidance value (HB2GV) dashboard.
    Nakayama SF; St-Amand A; Pollock T; Apel P; Bamai YA; Barr DB; Bessems J; Calafat AM; Castaño A; Covaci A; Duca RC; Faure S; Galea KS; Hays S; Hopf NB; Ito Y; Jeddi MZ; Kolossa-Gehring M; Kumar E; LaKind JS; López ME; Louro H; Macey K; Makris KC; Melnyk L; Murawski A; Naiman J; Nassif J; Noisel N; Poddalgoda D; Quirós-Alcalá L; Rafiee A; Rambaud L; Silva MJ; Ueyama J; Verner MA; Waras MN; Werry K
    Int J Hyg Environ Health; 2023 Jan; 247():114046. PubMed ID: 36356350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A revised concept for deriving reference values for internal exposures to chemical substances and its application to population-representative biomonitoring data in German children and adolescents 2014-2017 (GerES V).
    Hoopmann M; Murawski A; Schümann M; Göen T; Apel P; Vogel N; Kolossa-Gehring M; Röhl C;
    Int J Hyg Environ Health; 2023 Aug; 253():114236. PubMed ID: 37579634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of Policy Relevant Human Biomonitoring Indicators for Chemical Exposure in the European Population.
    Buekers J; David M; Koppen G; Bessems J; Scheringer M; Lebret E; Sarigiannis D; Kolossa-Gehring M; Berglund M; Schoeters G; Trier X
    Int J Environ Res Public Health; 2018 Sep; 15(10):. PubMed ID: 30248963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A physiologically-based kinetic (PBK) model for work-related diisocyanate exposure: Relevance for the design and reporting of biomonitoring studies.
    Scholten B; Westerhout J; Pronk A; Stierum R; Vlaanderen J; Vermeulen R; Jones K; Santonen T; Portengen L
    Environ Int; 2023 Apr; 174():107917. PubMed ID: 37062159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human biomonitoring as a pragmatic tool to support health risk management of chemicals--examples under the EU REACH programme.
    Boogaard PJ; Hays SM; Aylward LL
    Regul Toxicol Pharmacol; 2011 Feb; 59(1):125-32. PubMed ID: 20933039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human biomonitoring initiative (HBM4EU) - Strategy to derive human biomonitoring guidance values (HBM-GVs) for health risk assessment.
    Apel P; Rousselle C; Lange R; Sissoko F; Kolossa-Gehring M; Ougier E
    Int J Hyg Environ Health; 2020 Sep; 230():113622. PubMed ID: 33045523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomonitoring Equivalents for benzene.
    Hays SM; Pyatt DW; Kirman CR; Aylward LL
    Regul Toxicol Pharmacol; 2012 Feb; 62(1):62-73. PubMed ID: 22178585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human biomonitoring guidance values (HBM-GVs) for priority substances under the HBM4EU initiative - New values derivation for deltamethrin and cyfluthrin and overall results.
    Apel P; Lamkarkach F; Lange R; Sissoko F; David M; Rousselle C; Schoeters G; Kolossa-Gehring M
    Int J Hyg Environ Health; 2023 Mar; 248():114097. PubMed ID: 36577283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of human biomonitoring data in a health risk based context: An updated analysis of population level data from the Canadian Health Measures Survey.
    Faure S; Noisel N; Werry K; Karthikeyan S; Aylward LL; St-Amand A
    Int J Hyg Environ Health; 2020 Jan; 223(1):267-280. PubMed ID: 31523017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.